Manganese Injection, Solution
NDC Package 0409-4091-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Manganese (manganese chloride) injection is manganese 0.1 mg/mL (Manganese Chloride Injection, USP) is indicated for use as a supplement to intravenous solutions given for TPN.Administration helps to maintain manganese serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms. This formulation utilizes a injection, solution delivery system. Marketed by Hospira, Inc., this product is identified by NDC 0409-4091 and is authorized under FDA application NDA018962.

Identification & Billing

NDC Package Code
0409-4091-01
Package Description
25 VIAL, PLASTIC in 1 TRAY / 10 mL in 1 VIAL, PLASTIC (0409-4091-11)
Product Code
0409-4091
11-Digit Billing Format
00409409101
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Manganese
Non-Proprietary Name
Manganese Chloride
Substance Name
Manganese Chloride
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
MANGANESE CHLORIDE .1 mg/mL
Pharmacologic Class
Usage Information
Manganese 0.1 mg/mL (Manganese Chloride Injection, USP) is indicated for use as a supplement to intravenous solutions given for TPN.Administration helps to maintain manganese serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.

Regulatory & Marketing

Labeler Name
Hospira, Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA018962
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-31-2005
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0409-4091-01 identifies a specific commercial package of 25 vial, plastic in 1 tray / 10 ml in 1 vial, plastic (0409-4091-11) of Manganese, a human prescription drug labeled by Hospira, Inc.. This injection, solution is formulated for intravenous use and contains manganese chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hospira, Inc. on January 31, 2005. The current certification is valid through December 31, 2027.

How is this Hospira, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00409409101. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0409-4091-01
11-Digit CMS (5-4-2)
00409-4091-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.